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ABSTRACT 
Objective 
This study evaluates the roles of medical and social complexity in health care use outcomes in 
cystic fibrosis (CF) after transfer from pediatric to adult care.  
Methods 
Retrospective cohort design included patients with CF who were transitioned into adult care at 
Indiana University from 2005 to 2015. Predictor variables included demographic and 
comorbidity data, age at transition, treatment complexity score (TCS), and an objective scoring 
measure of their social complexity (Bob’s Level of Social Support, BLSS). Outcome variables 
included outpatient visit rates and hospitalization rates. Pearson’s correlations and linear 
regression were used to analyze the data. 
Results 
The median age of the patients (N=133) at the time of transition was 20 (IQR 19-23) years. The mean 
FEV1 % predicted at transition was 69 ± 24%. TCS correlated with outpatient visit rates (r = 0.3, p 
= 0.003), as well as hospitalization rates (r = 0.4, p < 0.001); while the BLSS only correlated with 
hospitalization rates (r = 0.7, p < 0.001).  After adjusting for covariates, the strongest predictors of 
post-transfer hospitalizations are BLSS (p <0.0001) and pre-transfer hospitalization rate (p 
<0.0001).   
Conclusion 
Greater treatment complexity is associated with greater healthcare utilization overall, while 
greater social complexity is associated with increased hospitalizations (but not planned 
outpatient visits). Screening young adults for social complexity will identify high-risk 
subpopulations and allow for patient centered interventions to support them and prevent 
avoidable health care use. 
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INTRODUCTION 
Cystic fibrosis (CF) is the most common multi-organ genetic disease in the Caucasian 
population affecting more than 70,000 people worldwide1. Due to advances in medical treatment, 
outcomes have improved over the last several decades2.  In 2014, 50.7% of patients in the US CF 
Patient Registry (CFPR) were 18 years old and over, and this number has continued to 
increase1,3. The rising adult demographic underscores the need for adult-oriented care and age-
appropriate management. The US Cystic Fibrosis Foundation (CFF) has long supported the 
development of adult CF programs. However, best practices surrounding transfer of care from 
pediatric to adult programs rely heavily on expert opinion, and the lack of outcomes data has left 
providers to make transition-related decisions without evidence-based guidelines4. 
Adolescence is a vulnerable developmental period where puberty and brain maturation 
lead to new behaviors that set the future trajectory toward health and well-being5. The literature 
regarding social determinants of health (SDH) in adolescence is expanding5,6. Income, education, 
and family support influence adolescent health throughout the transition into adulthood5. SDH 
add another layer to medical complexity for patients with CF, likely influencing a patient’s 
readiness to transition, increasing the support required to successfully transfer care, and affecting 
general health outcomes.  
While data demonstrate that transfer to adult care does not necessarily exacerbate lung 
function decline in patients with CF, there is a paucity of data exploring health care utilization 
after transfer7,8. Additionally, the effects of SDH on health services outcomes are poorly 
understood. Most of the current research with SDH in CF explores associations between clinical 
outcomes and various patient or family psychosocial factors. Health care utilization data, such as 
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adherence, hospitalizations, emergency department visits, and outpatient visits may better reflect 
outcomes related to social and psychological characteristics, rather than clinical outcomes alone9-
12. 
This study evaluates the roles of medical and social complexity on health care utilization 
outcomes in CF after transfer into adult care. We hypothesize that individuals with high disease 
complexity or high social complexity experience increased health care utilization after transfer. 
METHODS 
A retrospective cohort study was conducted using data from patients in the CFF-
accredited CF program at Indiana University (IU). All patients with a diagnosis of CF who 
transferred to the adult CF program at IU from January 2005 to December 2015 were included. 
Patients were diagnosed with CF by clinical features confirmed with either elevated sweat 
chloride (≥ 60 mmol/L), or genotype with two identifiable CFTR mutations. Patients were 
included if they had received care at Riley Hospital for Children and then transferred to the IU 
Adult CF Program at University Hospital; they were excluded if they had transferred to the adult 
program from a center outside of IU. Overall 133 patients were eligible to be included in the 
study.  
Data Collection 
Data from the electronic medical record, CFPR, paper charting, and storage on body 
plethysmographers (Morgan Scientific, Inc., Haverhill, MA) was extracted to obtain the 
longitudinal data used in this study. Data points were collected at the time of transfer (time 0); 
the preceding 24 months, 12 months, and 6 months prior to transfer; and the subsequent 6 
months, 12 months, and 24 months after transfer. Time 0 was determined to be the date at which 
a patient had the first visit with an adult provider. This occurred either as a transition visit (when 
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the adult provider saw the patient at the children’s hospital), the first adult hospital admission 
without a previous adult outpatient visit, or the first appointment at the adult CF outpatient 
center.  
General demographic data that is included in the CFPR such as age, gender, race, marital 
status, employment status, living situation, education, income and insurance were collected at 
time 0. CF specific comorbidities, such as Pseudomonas aeruginosa microbiology, sinus disease, 
CF-related diabetes, pancreatic insufficiency, liver disease, as well as anxiety and depression 
were collected as categorical variables (present or not) within 2 years of time 0. Anxiety and 
depression were considered present if the patient had a corresponding diagnosis code or there 
was documentation in the clinical notes mentioning one of these diagnoses.  Absolute FEV1 at 
time 0 was converted to FEV1 % predicted using Hankinson’s formula for standardization13.   
Outcome variables included average yearly number of outpatient visits pre- and post- 
transfer and average yearly number of hospitalizations pre- and post- transfer. Study data were 
collected and managed using REDCap electronic data capture tools14. One hundred and thirty-
three patients were eligible for data collection; all were included in analysis for demographic 
data. Eleven patients did not have enough information to score the social complexity scale and 
were excluded from health services outcomes analyses.  
Defining Treatment Complexity and Social Complexity 
The treatment complexity score (TCS) has been previously published and is a composite 
number derived from 37 chronic CF therapies15. Higher scores signify a more complex medical 
regimen. The more labor intensive medications, such as insulin or multiple daily dosing of 
inhaled antibiotics, are given a score of 3; those that are less onerous, such as vitamins and thrice 
weekly azithromycin, are given a score of 1; and those intermediate, such as dornase alfa and 
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pancreatic enzymes, are given a score of 215. In our study TCS was calculated based on the 
medication list at time 0 and used in correlations and as a covariate in logistic regression.  
The Bob’s Level of Social Support scale (BLSS) was designed for use in a developmental 
pediatrics clinic to screen families’ needs for increased care management support (Nickel R. 
Bob’s Level of Social Support.; 2011)(Supplementary Data 1). We utilized BLSS as a measure of 
social complexity, defined as SDH having a direct or indirect impact on health outcomes. The 
BLSS is divided into five dimensions: overall health, family, behavioral and mental health, 
education, and special issues. Each is rated from 1-3, with total BLSS scores ranging from 5-15. 
Special issues include ability to follow through with recommendations, cultural issues as barriers 
to care, and ability to proactively manage care. Higher scores indicate the presence of more 
complex psychosocial factors. The BLSS is not a validated tool; it has not been studied to 
measure health outcomes. However, it is a complexity tool that is both available for public use 
and includes family and social factors. The BLSS score is based on documentation from social 
work, care management, and physician notes at time 0. BLSS scores were compiled 
retrospectively by EC, and CB performed a reliability audit of these scores.  
Statistical Analysis 
Averages and frequencies of demographic data were determined using descriptive 
statistics. Inter-rater reliability for the audited BLSS and TCS scores were calculated using intra-
class correlation. Pearson product moment correlation was used to determine relationships 
between TCS, BLSS, and hospitalization rates and outpatient visit rates. Multivariable linear 
regression was used to predict post- transfer hospitalizations from several variables that were 
significant with bivariate linear regression: age at transfer, FEV1 % predicted at transfer, BLSS, 
TCS, depression, pre-transfer hospitalizations, post-transfer outpatient visits, and gaps in care.  
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Covariates were included in the model if the p-value ≤ 0.05. All analyses were conducted 
with SPSS versions 23 and 24 (IBM Corp. New York, 2015) statistical software.  The 
Institutional Review Board at IU approved this study (Protocol ID 1509912571).  
RESULTS 
Median age at transfer was 20 (IQR 19-23) years, and female patients comprised 48% of 
the group (Table 1). The demographic characteristics were comparable to the general adult CF 
population as reported in the CFPR1; however, we had more patients with Pseudomonas 
aeruginosa infection (64% vs 47.5%), and depression (32% vs 24.1%), and fewer patients with 
CF-related diabetes (25% vs 34.9%). 
Inter-rater Reliability for Scales 
Audited inter-rater reliability was completed for both the TCS and BLSS for a random 
sample of 50% (67/133) of the subjects. A high degree of reliability was found between the total 
scores on the TCS (κ = 0.93, CI 0.89, 0.96) and BLSS (κ = 0.93, CI 0.89, 0.96). Reliability was 
also tested between the individual scores of the different domains of the BLSS: health (κ = 0.71, 
CI 0.52, 0.83), family (κ = 0.87, CI 0.78, 0.92), behavioral and mental health (κ = 0.85, CI 0.75, 
0.91), education (κ = 0.77, CI 0.62, 0.87), special issues (κ = 0.52, CI 0.19, 0.72).       
Health Services Outcomes Analysis 
Among the overall population, there was a decrease in the number of outpatient visits per 
year after transfer and an increase in the number of hospitalizations per year. However, this was 
not statistically significant (Table 2). A higher TCS correlated with outpatient visit rates before 
and after transfer (r = 0.31, p = 0.003, and r = 0.33, p < 0.001, respectively as well as 
hospitalization rate before and after transfer (r = 0.45, p < 0.001, and r = 0.41, p < 0.001, 
respectively). A higher BLSS did not correlate with outpatient visit rates before or after transfer 
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(r = -0.03, p = 0.8, and r = 0.08, p = 0.36, respectively). However, there was a strong positive 
correlation between BLSS and hospitalization rates before and after transfer (r = 0.7, p < 0.001, 
and r = 0.72, p < 0.001, respectively). 
Multivariable linear regression was performed to ascertain the effects of gap in care (categorical 
variable defined as the number of days between the last pediatric and first adult visit or 
hospitalization: ≤ 100 days, 101-364 days, or ≥ 365 days), age at transfer, outpatient visits post-
transfer, pre-transfer hospitalization rate, FEV1 % predicted at transfer, depression, BLSS, and 
TCS on the number of post-transfer hospitalizations. The model demonstrated BLSS and pre-
transfer hospitalization rate to be the only significant predictors of post- transfer hospitalization 
(Table 3). After adjusting for covariates, for every one point increase in the BLSS, the number 
of hospitalizations will increase by 0.5 and for every hospitalization prior to transfer, the number 
of post-transfer hospitalizations will increase by 0.6. This relationship is illustrated graphically 
(Figure 1).       
  
DISCUSSION 
In adults with CF, treatment complexity correlated with health care utilization for both 
outpatient visits and hospitalizations, and social complexity significantly correlated with 
hospitalizations but not outpatient visits. Increased social complexity is a strong predictor of 
hospitalization after transfer to adult care even after accounting for treatment complexity and 
hospitalization rate prior to transfer. 
Most commonly used disease complexity scores use medical data alone without 
consideration of environmental influences16. Previous literature in CF regarding SDH explores 
maternal education attainment, family discord, and socioeconomic status (SES) as factors 
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affecting outcomes in CF. Low SES is associated with significantly poorer clinical outcomes in 
CF, including: lower FEV1, lower BMI, and more frequent pulmonary exacerbations17-20.  We 
used a novel scale to measure social complexity, which incorporates several SDH, rather than 
SES alone.  
Both treatment complexity and social complexity influenced health care utilization 
outcomes. It is known that SDH can negatively affect health care use despite equal access to 
care21.  A study of the effect of SES, Medicaid status, and maternal education attainment in 
pediatric patients with CF showed that individuals with Medicaid were found to have the most 
outpatient sick visits. It further demonstrated that lower maternal education attainment was 
associated with having fewer exacerbations treated with home IV antibiotics, despite the number 
of stable visits being consistent across groups19. In a study of pediatric patients performed in 
Western Australia, marital discord and family psychological distress were significant predictors 
of increased hospitalizations, emergency, and outpatient visits in early life CF after adjusting for 
disease severity22.  In a population of pediatric patients with noncomplex chronic conditions, it 
was found that having social complexity risk factors were significantly associated with the need 
for care coordination23.  
 As previously defined, the TCS was studied to evaluate change in medical complexity 
over time and site-specific health outcomes, but has not been used as a predictor of health-related 
outcomes15. This study demonstrated that the TCS significantly correlated with both outpatient 
visit rates and hospitalization rates before and after transfer. These results are intuitive, as 
patients’ disease progresses, their medical regimen is likely to become more complicated. 
Additionally, they are likely to be seen more frequently and have more frequent hospitalizations 
for disease-related issues. 
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A recent study validated social complexity risk factors in relation to care-giver reported 
need for care coordination23.  This study used state administrative data to collect social 
complexity risk factors; several of these are the SDH captured by the BLSS. Like the TCS, the 
BLSS has not been studied or used as a predictor of health care outcomes. Strikingly, the BLSS 
correlated more strongly with hospitalization rates before and after transfer, while it did not 
correlate with outpatient visit rates. Arguably, hospitalizations are unplanned sequela of poor 
disease control, while outpatient visits are planned attempts to prevent these sequelae.  These 
results support the hypotheses that patients with higher BLSS scores are more likely to have a 
lack of ability to navigate the health care system, unstable disease due to psychosocial factors out 
of proportion to disease phenotype, and a lack of resources or support outside of the healthcare 
environment that leads to hospitalization rather than outpatient visits. 
When transferring a patient with CF into adult care, it is imperative to recognize and 
acknowledge not only the developmental needs but also the relevant SDH in order to 
communicate the need and provide appropriate levels of support to foster independence and 
successful self-care. While prospective validation of the BLSS needs to be performed, this study 
suggests that the BLSS may have value as a screening tool for health care use outcomes among 
this population.  Prior observational analyses have shown that hospitalizations in patients with 
cystic fibrosis are independent predictors of lung function decline and that a pulmonary 
exacerbation treated with intravenous antibiotics is a strong risk factor for future courses of 
intravenous antibiotics24,25. Furthermore, SES, environmental factors, and insurance status may 
influence whether a patient receives intravenous antibiotics at home or is hospitalized for the 
duration of therapy. Taking the risk of a prior hospitalization leading to a future hospitalization 
into account, we included this in our multivariable analysis to see how it interacted with social 
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complexity. We found that along with pre-transfer hospitalization rate, the BLSS is a strong 
contributor to the post-transfer hospitalization rate. This result is consistent with the correlations 
between BLSS scores and hospitalizations, both before and after transfer of care, as those 
patients with high BLSS sustained increased hospitalizations.     
Our study has several limitations.  First, it is a retrospective review from a single center. 
One of the challenges of research surrounding transition is the variability across center practices. 
While the transition practices at Indiana University might not be generalizable, our patient 
population was consistent with that in the 2015 CFPR. Second, the time period of our study was 
over 4 years and this might not be enough time to fully appreciate a clinical decline in otherwise 
stable patients, and two years after transfer might not be long enough to capture those patients 
who become fully independent. We collected the CF-specific comorbidities and demographic 
variables of marital status, employment status, schooling, etc at the time of transfer. We chose 
this approach in an attempt to better understand the population transferring into our adult 
program. However, it is likely that these specific demographics would change in the four years 
of this study, particularly over the age range of transfer (19-23 years old) in this study. Transition 
and transfer not only reflect changes in medical care but also in life, specifically as an adolescent 
moves towards independence.  These changes would likely have an influence on the outcomes 
measured in the two years after transfer, in either a positive or negative way. For instance, if a 
subject was employed, you would hypothesize that this could be a positive factor - in that they 
now have steady insurance through an employer. This could also be a negative effect, in that now 
they have less time for treatments. Likewise, you might hypothesize that the subject’s 
educational attainment might heavily influence their health literacy. Thirdly, the TCS score was 
based on a medication list, rather than patient interview or refill records and does not account for 
SOCIAL COMPLEXITY AFFECTS OUTCOMES IN CF AFTER TRANSFER 12 
patient adherence.  Lastly, neither the TCS nor BLSS have been validated to predict health care 
outcomes.  While the BLSS appears to be a valuable tool, and we worked to operationalize 
definitions for each domain relevant to the cystic fibrosis population, another limitation of this 
scale is the “Special Issues” domain.  This domain is a broad category that is probably influenced 
most by subjective assessment. It was scored in the moderate range, as the least closely aligned 
item and may benefit from more clarity of anchor definitions.     
CONCLUSION 
 Our study demonstrates a strong correlation between complicated social situations and 
increased, sustained hospitalization rates before and after transfer to adult care. Additionally, 
social complexity as measured by the BLSS, along with pre-transfer hospitalizations are 
significant predictors of future hospitalizations. From this study, we can conclude that those 
subjects with increased social complexity sustain an increased rate of hospitalization before and 
after transfer, whereas outpatient visits decrease. This study is an early step towards 
understanding the important psychosocial and family factors that influence health care utilization 
outcomes in the CF population. Future studies are required to externally validate the BLSS, as a 
quick and complete screening tool to identify patients who are at risk for increased health care 
utilization. This could lead to successful interventions delivered through a high-risk period of 
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Table 1: Characteristics of the study population in comparison to national population 
 Study Population, 
N = 133 
CFPR Data1 
N= 28,983 
Age at transfer in years (IQR) 20 (19-23) N/A 
Female, % 48 48.4 
Caucasians, % 97 93.8 
Employed, % 47 48.8 
Living independently, % 33 N/A 
High school or less education, % 34 31 
Public insurance, % 55 44.8 
FEV1, % predicted (SD) 69 (24) 67.1 
TCS (IQR) 14 (10-18) N/A 
BLSS (SD) 7 (6-9) N/A 
Data presented as median (IQR, interquartile range) and mean (SD, standard deviation) unless 
otherwise specified 
Public insurance includes Medicare/Medicaid and Children’s special health care 
N/A, not collected for CFPR 
CFPR, Cystic Fibrosis Patient Registry 
TCS, treatment complexity score 
BLSS, Bob’s level of social support 
FEV1, Forced Expiratory Volume in 1 second 
 
Table 2: Social complexity and treatment complexity associations with health care use outcomes 
  Study Population,  
N = 122 
Correlation 
with TCS (R) 
Correlation 
with BLSS (R) 
Average annual 
outpatient visits (SD) 
    
 Pre-transfer 4.0 (2.8) 0.31† -0.028 
 Post-transfer 3.6 (2.0) 0.33* 0.08 
Average annual 
hospitalizations (SD) 
    
 Pre-transfer 1.1 (1.7) 0.45* 0.70* 
 Post-transfer 1.4 (2.3) 0.41* 0.72* 
Data presented as mean (SD, standard deviation) unless otherwise specified 
*p <0.001, †p <0.05 
 
Table 3: Social complexity has a strong influence on post-transfer hospitalization rate1  
Risk Factor Coefficient (β)  Confidence Interval P-value 
BLSS 0.46 (0.28, 0.64) < 0.0001 
Gap in Care -0.26 (-0.68, 0.16) 0.22 
Outpatient Visit Rate (post-
transfer, per year) 
0.08 -0.08, 0.23 0.33 
FEV1 % predicted at transfer -0.004 (-0.02, 0.008) 0.54 
Depression 0.09 (-0.27, 0.45) 0.61 
TCS 0.005 (-0.05, 0.06) 0.86 
Age at Transfer -0.003 (-0.05, 0.04) 0.88 
Hospitalization Rate  
(pre-transfer, per year) 
0.60 (0.36, 0.83) < 0.0001 
1Variables included had a significant relationship with post-transfer hospitalization rate in 
bivariate analysis.  adjusted R2 = 0.72, N = 122 
Post-transfer Hospitalizations = (0.46 * BLSS) + (0.6 * pre-transfer hospitalization rate) – 2.7  
BLSS, Bob’s level of social support 





Figure 1: Subjects with increased social complexity and increased pre-transfer hospitalizations 
had increased hospitalizations after transfer to adult care to a greater degree than those with 
increased social complexity and fewer pre-transfer hospitalizations. This graph shows the 
distribution of patients when divided into 2 groups: ≤ 1 hospitalization in the 2 years prior to 
transfer (black) or ≥ 2 hospitalizations in the 2 years prior to transfer (grey). As the social 
complexity increases (BLSS score), so does the number of overall hospitalizations both before 
and after transfer. It also shows that in the patients with high BLSS, pre-transfer hospitalization 
seems to have an influence on the number of post-transfer hospitalizations.  
Several points are overlapping.   
BLSS, Bob’s level of social support 
 
